Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch
Editor’s note: etnet interviewed Chairman and CEO Steve Rhodes on a range of subjects from the most recent Showcase to portfolio companies Leviticus Cardio and BioFishency.
By Andrew Vanburen, etnet (7 April 2017)
Last week, the Singapore listco held its 7th Annual Trendlines Company Showcase at Kibbutz Shefayim, Israel.
Of the half-dozen medical technology and three agricultural technology firms presenting at the Company Showcase, which among them elicited more head-turning investor and/or technical interest, and why do you think this was the case?
Mr. Steve Rhodes, Chairman and CEO, The Trendlines Group Ltd: This is a very difficult question, especially since I think many (or even most) of the companies attracted a lot of attention.
Having said that, I think that our two female CEOs may have attracted the most attention.
Dr. Edit Goldberg of Escala Medical did a great job presenting the company’s unique technology for a nonsurgical, mesh-free repair of pelvic organ prolapse, a painful condition that affects millions of women around the world.